Professional Documents
Culture Documents
April 2009
Summarize relationship between exposure and disease by comparing at least two frequencies in a single summary estimate. Overall rate of disease in an exposed group says nothing about whether exposure is a risk factor for or causes a disease.
This can only be evaluated by comparing disease occurrence in an exposed group to another group that is usually not exposed. The latter group is usually called the comparison or reference group.
Comparing Ratios
Exposure
No Total
Prevalence or cumulative incidence = a/(a+b) among exposed = c/(c+d) among unexposed = (a+c)/(a+b+c+d) among total population
Example #1
Data from a fixed cohort study of oral contraceptive use (OC) and myocardial infarction (MI) in pre-menopausal women followed for 5 years (adapted from Rosenberg et al AJE 1980). MI
Yes No Total
Yes
23
133 156
304
2816 3120
327
2949 3276
OC use
No Total
5-year CI of myocardial infarction = 23/327 = 7.0% among OC users = 133/2949 = 4.5% among non-OC users
a c a+c
Exposure
No Total
Incidence rates = a/(PTexp) among exposed = c/(PTunexp) among unexposed = (a+c)/(Total PT) among total population
PH use
No Total
Relative Comparisons
Based on ratio of 2 measures of frequency Often referred to as relative risk Dimensionless and ranges 0 - infinity
Prevalence ratio (PR) = Pexp / Punexp = [a / (a+b)] / [c / (c+d)] Cumulative incidence ratio (CIR) = CIexp / CIunexp = [a / (a+b)] / [c / (c+d)] Incidence rate ratio (IRR) = IRexp / IRunexp = [a / PTexp] / [c / PTunexp ]
Example #1 (continued)
MI
Yes Yes 23 133 No 304 2816 Total 327 2949
OC use
No
Total
156
3120
3276
5-yr CIR of MI among OC users compared to non OC users: 5-yr CIR= CIe/CIu = [a/(a+b)]/[c/(c+d)] = (23/327)/(133/2949) = 1.6 Interpreted as relative risk: 1. Women who used OCs had 1.6 times the risk of having MI over 5 years compared to non-OC users (1.6-fold increased risk). 2. There is a 60% increase risk of MI among OC users over a 5-yr period compared to non-users (60% more likely to have MI).
Example #2 (continued)
CHD
Yes No --Total 54,308 PY
PH use
Yes
30
No
Total
60
90
-----
51,477 PY
105,786 PY
Incidence rate ratio of CHD among PH users compared to non-PH users: IRR = IRe/IRu = [a/PTe]/[c/PTu] = 0.5 Interpreted as a relative risk: Women who used PH had 0.5 times, or half, the risk of developing CHD compared to non-users.
RR>1
Risk in exposed > risk in non-exposed Positive association, factor is associated with disease Larger RR stronger association
RR<1
Risk in exposed < risk in non-exposed Negative association, factor is protective
Total
35
1-4 years
5
7 7 133 156
107
127 39 2816 3120
112
134 46 2949 3276
OC use
The 5-yr CIR (relative risk) of MI among users of OC for greater than 10 years compared to never users is (7/46) / (133/2949) = 3.4.
The 5-yr CIR (relative risk) of MI among users of OC for greater than 10 years compared to users of 5-9 years is (7/49) / (7/134) = 2.7
Case-Control Studies
Participants are selected for study participation on the basis of pre-existing disease status Cannot estimate prevalence, CI, or IR
Do not know the population at risk
Cannot use previous formulas Relative risk can be estimated by odds ratio (OR)
ratio of odds of exposure among cases to odds of exposure among controls
OR = (a/c)/(b/d) = ad/bc
No
Yes No Disease
Exposure No
Toxic shock syndrome Cases Tampon brand used during month of illness Rely Other Total 15 9 24 Controls 14 45 59 Total (29) (54) (83)
OR = (15*45)/(14*9) = 5.4 Interpretations: The odds of using Rely tampons among women with TSS were 5.4 times higher than the odds of using Rely tampons among those without TSS (technical) Women who used Rely tampons were 5.4 times more likely to develop toxic shock syndrome than women who used other brands (loosely).
To do this, one would need to know the number of all cases of TSS among women (numerator) and the number of all women who are at risk (denominator).
Usually, denominator data are not available and numerator data may be incomplete in case-control studies.
Comparing Differences
Risk Difference
Risk difference (RD) = Rexp Runexp
For Prev*: RD = Pexp - Punexp = a / (a+b) c / (c+d) For CI: RD = CIexp - CIunexp = a / (a+b) c / (c+d) For IR: RD = IRexp - IRunexp = a / PTexp c / PTunexp
* Some epidemiologists hesitate to use risk when referring to prevalence estimates More precisely called prevalence difference, cumulative incidence difference, and incidence rate difference Also called attributable risk, rate difference, attributable rate
Note: attributable implies causality RD = 0 when there is no association between exposure and disease
What we can hope to accomplish in reducing risk of disease among exposed if exposure were eliminated
Example #4
(adapted from Boice 1977 JNCI)
PY 28,010 19,017
56
47,027
11.9
Interpretation:
Broad: there are 6.7 excess cases of breast cancer for every 10,000 PY among those exposed to radiation compared to those not exposed. Narrow: Eliminating this radiation would prevent 6.7 cases of breast cancer for every 10,000 PY (attribution).
RR
RD
14.0
130/100,000/YR
1.6
256/100,000/YR
Conclusion: Cigarette smoking is a much stronger risk factor for lung cancer but (assuming smoking is causally related to both diseases) the elimination of cigarette smoking would prevent far more deaths from coronary heart disease. Why is this so? Death from CHD is much more common.
In Other Words
Relative risk is a measure of strength of association between exposure and disease and is useful in analytical studies
risk
Relative difference is a measure of how much disease incidence is attributable to exposure, and is useful in assessing exposures public health importance
burden
PRD = (RD)*(PPexp) where PPexp is % of population that is exposed Note (as always) that risk may refer to IR or CI (more accurately) or prevalence (less accurately)
Example #4 Revisited
Breast cancer cases
Radiation exposure No radiation exposure Total 41 15 56 PY 28,010 19,017 47,027 Rates/10,000 PY 14.6 7.9 11.9
Interpretation: 4 excess breast cancer cases for every 10,000 PY of observation can be attributed to radiation exposure. If radiation causes breast cancer, then 4 cases of breast cancer for every 10,000 person-years of observation could be prevented if the radiation exposure were removed.
Alternative formula
Again, we are interested in the difference between the risk in the exposed and risk in the unexposed:
APe = [(Re Ru)/Re] * 100 Divide numerator and denominator by Ru APe = [(RR-1)/RR] * 100 (Different formulas may be helpful depending on what information you have.)
32
33
Example
(continued)
PY
Rates/10,000 PY
APe = [(14.6 7.9)/14.6] * 100 = 46% Interpretation: 46% of cases of breast cancer among those exposed to radiation may be attributed to radiation exposure and could be eliminated if exposure were removed.
APt = [(Rt Ru)/Rt] * 100 = PRD / Rt * 100 Rt = risk (IR, CI, P) among total population Ru = risk (IR, CI, P) among unexposed
Alternative formulas
APt = [1 - (Ru / Rt)] * 100 APt = [(Pe)(RR-1)]/[(Pe)(RR-1)+1] * 100
For case-control studies:
APt = [(Pe)(OR-1)]/[(Pe)(OR-1)+1] * 100
Example
(continued)
PY
Rates/10,000 PY
Yes Delegate
Convention Status
No 1724 759
125 3
NonDelegate
What is the relative risk of Legionnaires disease among delegates compared to non-delegates?
First: what type of measure is this?
RR =
Interpretation:
What is the risk difference for Legionnaires disease among delegates vs. non-delegates?
First, what type of measure is this?
RD =
Interpretation:
Interpretation:
Yes Hotel A
Other Hotel
No 628
1,098
Total 690
1,161
62
63
CIR = Interpretation:
Key points
Relative and absolute measures of comparison tell us different things
Relative risk is a measure of strength of association; often of interest to epidemiologists who do etiologic research Absolute risk then becomes important (assuming causality) to public health planners, policy makers, etc. for estimating public health impact of exposures on communities
Measures go by different names and multiple formulas are sometimes available. It is important to
know what you are interesting in measuring, know what data are available and in what form, and if data are not available, know how to collect appropriate data.